ReviewMetabolites2020

NLRP3 Inflammasome Biomarker-Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome.

Andra-Iulia Suceveanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.